Bone Conduction Implants: Comparative of Audiometric Results and Quality-of-Life Bonebridge® versus Osia®.

IF 1.6 4区 医学 Q2 AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY
Audiology and Neuro-Otology Pub Date : 2024-01-01 Epub Date: 2024-02-20 DOI:10.1159/000537868
Joan Lorente-Piera, Raquel Manrique-Huarte, Janaina Patricio de Lima, Alicia Huarte-Irujo, Manuel Manrique
{"title":"Bone Conduction Implants: Comparative of Audiometric Results and Quality-of-Life Bonebridge® versus Osia®.","authors":"Joan Lorente-Piera, Raquel Manrique-Huarte, Janaina Patricio de Lima, Alicia Huarte-Irujo, Manuel Manrique","doi":"10.1159/000537868","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Bone conduction implants have been indicated for patients with conductive hearing loss, mixed hearing loss, and even profound unilateral sensorineural hearing loss. With the introduction of Bonebridge®, new transcutaneous implant options emerged. The latest is Osia®, a direct-drive variant or active systems, where the implant directly generates and applies vibration to the bone.</p><p><strong>Materials and methods: </strong>Retrospective study of two cohorts of patients treated with active bone conduction implants at a single center, one with the Bonebridge® device and the other with Osia®.</p><p><strong>Outcomes: </strong>Fourteen patients were included, seven in each group (n = 14). The Bonebridge® group showed an average hearing gain in tonal intelligibility thresholds of 32.43 ± 21.39 dB and a gain in the average intelligibility threshold (with 50% discrimination) of 26.29 ± 19.10 dB. In the Osia® group, there was a gain in average tonal thresholds of 41.49 ± 14.16 dB and 23.72 ± 6.98 dB in average intelligibility thresholds. Both devices contributed to improvements in patients' quality of life, as assessed with APHAB in all the variables studied in the test. Both devices offer rehabilitation for hearing loss as an alternative to hearing aids. The Osia® system shows statistically significant (p &lt; 0.05) improvements in mid and high frequencies, but Bonebridge® slightly outperforms in speech understanding at 50%. Differences in average tonal thresholds and quality of life are not statistically significant.</p><p><strong>Conclusions: </strong>While auditory improvement is observed postimplantation, other aspects, such as intelligibility thresholds and quality of life, lack statistical significance. Given the limited experience with Osia® and the small sample size, the choice of the device should be personalized. Although the literature is inconsistent due to small sample sizes and variable approaches, some studies suggest potential advantages of the Osia® system, especially in speech comprehension in different environments and greater hearing gain compared to Bonebridge®.</p>","PeriodicalId":55432,"journal":{"name":"Audiology and Neuro-Otology","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Audiology and Neuro-Otology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000537868","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Bone conduction implants have been indicated for patients with conductive hearing loss, mixed hearing loss, and even profound unilateral sensorineural hearing loss. With the introduction of Bonebridge®, new transcutaneous implant options emerged. The latest is Osia®, a direct-drive variant or active systems, where the implant directly generates and applies vibration to the bone.

Materials and methods: Retrospective study of two cohorts of patients treated with active bone conduction implants at a single center, one with the Bonebridge® device and the other with Osia®.

Outcomes: Fourteen patients were included, seven in each group (n = 14). The Bonebridge® group showed an average hearing gain in tonal intelligibility thresholds of 32.43 ± 21.39 dB and a gain in the average intelligibility threshold (with 50% discrimination) of 26.29 ± 19.10 dB. In the Osia® group, there was a gain in average tonal thresholds of 41.49 ± 14.16 dB and 23.72 ± 6.98 dB in average intelligibility thresholds. Both devices contributed to improvements in patients' quality of life, as assessed with APHAB in all the variables studied in the test. Both devices offer rehabilitation for hearing loss as an alternative to hearing aids. The Osia® system shows statistically significant (p < 0.05) improvements in mid and high frequencies, but Bonebridge® slightly outperforms in speech understanding at 50%. Differences in average tonal thresholds and quality of life are not statistically significant.

Conclusions: While auditory improvement is observed postimplantation, other aspects, such as intelligibility thresholds and quality of life, lack statistical significance. Given the limited experience with Osia® and the small sample size, the choice of the device should be personalized. Although the literature is inconsistent due to small sample sizes and variable approaches, some studies suggest potential advantages of the Osia® system, especially in speech comprehension in different environments and greater hearing gain compared to Bonebridge®.

骨传导植入体:Bonebridge® 与 Osia® 听力测量结果和生活质量比较。
简介:骨传导植入体适用于传导性听力损失、混合性听力损失,甚至重度单侧感音神经性听力损失患者。随着 Bonebridge® 的推出,出现了新的经皮植入选择。最新的是 Osia®,这是一种直接驱动变体或主动系统,植入体直接产生振动并作用于骨骼:对在一个中心接受主动骨传导种植体治疗的两组患者进行回顾性研究,一组使用 Bonebridge® 设备,另一组使用 Osia®:共纳入 14 名患者,每组 7 人(n=14)。Bonebridge® 组显示,音调可懂度阈值的平均听力增益为(32.43±21.39)分贝,平均可懂度阈值(50% 分辨力)的增益为(26.29±19.10)分贝。在 Osia® 组中,平均音调阈值提高了(41.49±14.16)分贝,平均可懂度阈值提高了(23.72±6.98)分贝。根据 APHAB 对测试中所有变量的评估,这两种设备都有助于改善患者的生活质量。作为助听器的替代产品,这两种设备都能为听力损失患者提供康复治疗。Osia®系统具有显著的统计学意义(P结论):虽然植入后听力有所改善,但其他方面,如可懂度阈值和生活质量,则缺乏统计学意义。鉴于使用 Osia® 的经验有限且样本量较小,应根据个人情况选择设备。尽管由于样本量小、方法各异,文献报道并不一致,但一些研究表明,Osia® 系统具有潜在的优势,尤其是在不同环境下的言语理解能力以及与 Bonebridge® 相比更高的听力增益方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Audiology and Neuro-Otology
Audiology and Neuro-Otology 医学-耳鼻喉科学
CiteScore
3.20
自引率
6.20%
发文量
35
审稿时长
>12 weeks
期刊介绍: ''Audiology and Neurotology'' provides a forum for the publication of the most-advanced and rigorous scientific research related to the basic science and clinical aspects of the auditory and vestibular system and diseases of the ear. This journal seeks submission of cutting edge research opening up new and innovative fields of study that may improve our understanding and treatment of patients with disorders of the auditory and vestibular systems, their central connections and their perception in the central nervous system. In addition to original papers the journal also offers invited review articles on current topics written by leading experts in the field. The journal is of primary importance for all scientists and practitioners interested in audiology, otology and neurotology, auditory neurosciences and related disciplines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信